The antiviral cytokines IFN-α and IFN-β modulate parietal epithelial cells and promote podocyte loss: Implications for IFN toxicity, viral glomerulonephritis, and glomerular regeneration

American Journal of Pathology

Volumn 183, Issue 2, 2013, Pages 431-440

  Migliorini, Adriana ^a   Angelotti, Maria L ^b   Mulay, Shrikant R ^a   Kulkarni, Onkar O ^a   Demleitner, Jana ^c   Dietrich, Alexander ^c   Sagrinati, Costanza ^b   Ballerini, Lara ^b   Peired, Anna ^b   Shankland, Stuart J ^d   Liapis, Helen ^e   Romagnani, Paola ^b   Anders, Hans Joachim ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b UNIVERSITY OF FLORENCE   (Italy)

^c UNIVERSITY OF MUNICH   (Germany)

^d UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^e WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; DOXORUBICIN; PROTEIN P21;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL ACTIVATION; CELL CYCLE ARREST; CELL DEATH; CELL DIFFERENTIATION; CELL LOSS; CELL MATURATION; CELL MEMBRANE PERMEABILITY; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; EPITHELIUM CELL; FEMALE; GENE EXPRESSION; GLOMERULONEPHRITIS; GLOMERULOSCLEROSIS; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; KIDNEY CELL; KIDNEY DISEASE; MACROPHAGE; MITOSIS; MODULATION; MOUSE; NICK END LABELING; NONHUMAN; PODOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEINURIA; REGENERATION; STIMULATION; STOMACH PARIETAL CELL; VIRUS INFECTION;

ANIMALS; ANTIVIRAL AGENTS; CELL DEATH; CELL DIFFERENTIATION; CELL MOVEMENT; CELL PROLIFERATION; CELL SURVIVAL; CELLS, CULTURED; DOXORUBICIN; EPITHELIAL CELLS; FEMALE; GLOMERULONEPHRITIS; HIV INFECTIONS; HUMANS; INTERFERON-ALPHA; INTERFERON-BETA; KIDNEY GLOMERULUS; MICE; MICE, SCID; PODOCYTES; REGENERATION;

EID: 84880618088     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2013.04.017     Document Type: Article

References (55)

1. J.S. Berns, and R.D. Bloom Viral nephropathies: core curriculum 2008 Am J Kidney Dis 52 2008 370 381
2. R. Allam, J. Lichtnekert, A. Moll, A. Taubitz, V. Vielhauer, and H.J. Anders Viral RNA and DNA sense common antiviral responses including type I interferons in mesangial cells J Am Soc Nephrol 20 2009 1986 1996
3. R. Allam, R.D. Pawar, O.O. Kulkarni, V. Hornung, G. Hartman, S. Segerer, S. Akira, S. Endres, and H.J. Anders Viral 5'-triphosphate RNA and non-CpG DNA aggravate autoimmunity and lupus nephritis via distinct TLR-independent immune responses Eur J Immunol 38 2008 3487 3498
4. K. Flur, R. Allam, D. Zecher, O.O. Kulkarni, J. Lichtnekert, M. Schwarz, B. Beutler, V. Vielhauer, and H.J. Anders Viral RNA induces type I interferon-dependent cytokine release and cell death in mesangial cells via melanoma-differentiation-associated gene-5: implications for viral infection-associated glomerulonephritis Am J Pathol 175 2009 2014 2022
5. H. Hagele, R. Allam, R.D. Pawar, and H.J. Anders Double-stranded RNA activates type I interferon secretion in glomerular endothelial cells via retinoic acid-inducible gene (RIG)-1 Nephrol Dial Transplant 24 2009 3312 3318
6. H. Hagele, R. Allam, R.D. Pawar, C.A. Reichel, F. Krombach, and H.J. Anders Double-stranded DNA activates glomerular endothelial cells and enhances albumin permeability via a toll-like receptor-independent cytosolic DNA recognition pathway Am J Pathol 175 2009 1896 1904
7. L.C. Platanias Mechanisms of type-I- and type-II-interferon-mediated signalling Nat Rev Immunol 5 2005 375 386
8. A.J. Sadler, and B.R. Williams Interferon-inducible antiviral effectors Nat Rev Immunol 8 2008 559 568
9. L.A. Bruggeman, M.D. Ross, N. Tanji, A. Cara, S. Dikman, R.E. Gordon, G.C. Burns, V.D. D'Agati, J.A. Winston, M.E. Klotman, and P.E. Klotman Renal epithelium is a previously unrecognized site of HIV-1 infection J Am Soc Nephrol 11 2000 2079 2087
10. B. Celik, and P.S. Randhawa Glomerular changes in BK virus nephropathy Hum Pathol 35 2004 367 370
11. A.K. Khatua, H.E. Taylor, J.E. Hildreth, and W. Popik Non-productive HIV-1 infection of human glomerular and urinary podocytes Virology 408 2010 119 127
12. D. Marras, L.A. Bruggeman, F. Gao, N. Tanji, M.M. Mansukhani, A. Cara, M.D. Ross, G.L. Gusella, G. Benson, V.D. D'Agati, B.H. Hahn, M.E. Klotman, and P.E. Klotman Replication and compartmentalization of HIV-1 in kidney epithelium of patients with HIV-associated nephropathy Nat Med 8 2002 522 526
13. J. Strauss, C. Abitbol, G. Zilleruelo, G. Scott, A. Paredes, S. Malaga, B. Montane, C. Mitchell, W. Parks, and V. Pardo Renal disease in children with the acquired immunodeficiency syndrome N Engl J Med 321 1989 625 630
14. H.J. Anders, J. Lichtnekert, and R. Allam Interferon-alpha and -beta in kidney inflammation Kidney Int 77 2010 848 854
15. C. Sagrinati, G.S. Netti, B. Mazzinghi, E. Lazzeri, F. Liotta, F. Frosali, E. Ronconi, C. Meini, M. Gacci, R. Squecco, M. Carini, L. Gesualdo, F. Francini, E. Maggi, F. Annunziato, L. Lasagni, M. Serio, S. Romagnani, and P. Romagnani Isolation and characterization of multipotent progenitor cells from the Bowman's capsule of adult human kidneys J Am Soc Nephrol 17 2006 2443 2456
16. L. Lasagni, L. Ballerini, M.L. Angelotti, E. Parente, C. Sagrinati, B. Mazzinghi, A. Peired, E. Ronconi, F. Becherucci, D. Bani, M. Gacci, M. Carini, E. Lazzeri, and P. Romagnani Notch activation differentially regulates renal progenitors proliferation and differentiation toward the podocyte lineage in glomerular disorders Stem Cells 28 2010 1674 1685
17. E. Ronconi, C. Sagrinati, M.L. Angelotti, E. Lazzeri, B. Mazzinghi, L. Ballerini, E. Parente, F. Becherucci, M. Gacci, M. Carini, E. Maggi, M. Serio, G.B. Vannelli, L. Lasagni, S. Romagnani, and P. Romagnani Regeneration of glomerular podocytes by human renal progenitors J Am Soc Nephrol 20 2009 322 332
18. T. Ohse, J.W. Pippin, M.R. Vaughan, P.T. Brinkkoetter, R.D. Krofft, and S.J. Shankland Establishment of conditionally immortalized mouse glomerular parietal epithelial cells in culture J Am Soc Nephrol 19 2008 1879 1890
19. P. Mundel, J. Reiser, A. Zuniga Mejia Borja, H. Pavenstadt, G.R. Davidson, W. Kriz, and R. Zeller Rearrangements of the cytoskeleton and cell contacts induce process formation during differentiation of conditionally immortalized mouse podocyte cell lines Exp Cell Res 236 1997 248 258
20. I. Giaever, and C.R. Keese A morphological biosensor for mammalian cells Nature 366 1993 591 592
21. S.R. Mulay, D. Thomasova, M. Ryu, and H.J. Anders MDM2 (murine double minute-2) links inflammation and tubular cell healing during acute kidney injury in mice Kidney Int 81 2012 1199 1211
22. M. Ryu, O.O. Kulkarni, E. Radomska, N. Miosge, O. Gross, and H.J. Anders Bacterial CpG-DNA accelerates Alport glomerulosclerosis by inducing an M1 macrophage phenotype and tumor necrosis factor-alpha-mediated podocyte loss Kidney Int 79 2011 189 198
23. D.E. Henao, L.F. Arias, P.W. Mathieson, L. Ni, G.I. Welsh, J.C. Bueno, B. Agudelo, A.P. Cadavid, and M.A. Saleem Preeclamptic sera directly induce slit-diaphragm protein redistribution and alter podocyte barrier-forming capacity Nephron Exp Nephrol 110 2008 e73 e81
24. M. Ryu, A. Migliorini, N. Miosge, O. Gross, S. Shankland, P.T. Brinkkoetter, H. Hagmann, P. Romagnani, H. Liapis, and H.J. Anders Plasma leakage through glomerular basement membrane ruptures triggers the proliferation of parietal epithelial cells and crescent formation in non-inflammatory glomerular injury J Pathol 228 2012 482 494
25. D. Appel, D.B. Kershaw, B. Smeets, G. Yuan, A. Fuss, B. Frye, M. Elger, W. Kriz, J. Floege, and M.J. Moeller Recruitment of podocytes from glomerular parietal epithelial cells J Am Soc Nephrol 20 2009 333 343
26. L. Lasagni, and P. Romagnani Glomerular epithelial stem cells: the good, the bad, and the ugly J Am Soc Nephrol 21 2010 1612 1619
27. V.W. Lee, and D.C. Harris Adriamycin nephropathy: a model of focal segmental glomerulosclerosis Nephrology (Carlton) 16 2011 30 38
28. L. Galluzzi, I. Vitale, J.M. Abrams, E.S. Alnemri, E.H. Baehrecke, M.V. Blagosklonny, T.M. Dawson, V.L. Dawson, W.S. El-Deiry, S. Fulda, E. Gottlieb, D.R. Green, M.O. Hengartner, O. Kepp, R.A. Knight, S. Kumar, S.A. Lipton, X. Lu, F. Madeo, W. Malorni, P. Mehlen, G. Nunez, M.E. Peter, M. Piacentini, D.C. Rubinsztein, Y. Shi, H.U. Simon, P. Vandenabeele, E. White, J. Yuan, B. Zhivotovsky, G. Melino, and G. Kroemer Molecular definitions of cell death subroutines: recommendations of the Nomenclature Committee on Cell Death 2012 Cell Death Differ 19 2012 107 120
29. T. Niranjan, B. Bielesz, A. Gruenwald, M.P. Ponda, J.B. Kopp, D.B. Thomas, and K. Susztak The Notch pathway in podocytes plays a role in the development of glomerular disease Nat Med 14 2008 290 298
30. A.T. Petermann, J. Pippin, K. Hiromura, T. Monkawa, R. Durvasula, W.G. Couser, J. Kopp, and S.J. Shankland Mitotic cell cycle proteins increase in podocytes despite lack of proliferation Kidney Int 63 2003 113 122
31. J.W. Pippin, R. Durvasula, A. Petermann, K. Hiromura, W.G. Couser, and S.J. Shankland DNA damage is a novel response to sublytic complement C5b-9-induced injury in podocytes J Clin Invest 111 2003 877 885
32. H. Vakifahmetoglu, M. Olsson, and B. Zhivotovsky Death through a tragedy: mitotic catastrophe Cell Death Differ 15 2008 1153 1162
33. A.N. Theofilopoulos, R. Baccala, B. Beutler, and D.H. Kono Type I interferons (alpha/beta) in immunity and autoimmunity Annu Rev Immunol 23 2005 307 336
34. S.C. Satchell, O. Buchatska, S.B. Khan, G. Bhangal, C.H. Tasman, M.A. Saleem, D.P. Baker, R.R. Lobb, J. Smith, H.T. Cook, P.W. Mathieson, and C.D. Pusey Interferon-beta reduces proteinuria in experimental glomerulonephritis J Am Soc Nephrol 18 2007 2875 2884
35. A. Schwarting, K. Paul, S. Tschirner, J. Menke, T. Hansen, W. Brenner, V.R. Kelley, M. Relle, and P.R. Galle Interferon-beta: a therapeutic for autoimmune lupus in MRL-Faslpr mice J Am Soc Nephrol 16 2005 3264 3272
36. A.M. Fairhurst, C. Xie, Y. Fu, A. Wang, C. Boudreaux, X.J. Zhou, R. Cibotti, A. Coyle, J.E. Connolly, E.K. Wakeland, and C. Mohan Type I interferons produced by resident renal cells may promote end-organ disease in autoantibody-mediated glomerulonephritis J Immunol 183 2009 6831 6838
37. D.C. Nacionales, K.M. Kelly-Scumpia, P.Y. Lee, J.S. Weinstein, R. Lyons, E. Sobel, M. Satoh, and W.H. Reeves Deficiency of the type I interferon receptor protects mice from experimental lupus Arthritis Rheum 56 2007 3770 3783
38. M.L. Santiago-Raber, R. Baccala, K.M. Haraldsson, D. Choubey, T.A. Stewart, D.H. Kono, and A.N. Theofilopoulos Type-I interferon receptor deficiency reduces lupus-like disease in NZB mice J Exp Med 197 2003 777 788
39. P.Y. Lee, Y. Li, Y. Kumagai, Y. Xu, J.S. Weinstein, E.S. Kellner, D.C. Nacionales, E.J. Butfiloski, N. van Rooijen, S. Akira, E.S. Sobel, M. Satoh, and W.H. Reeves Type I interferon modulates monocyte recruitment and maturation in chronic inflammation Am J Pathol 175 2009 2023 2033
40. Y. Wang, Y.P. Wang, G. Zheng, V.W. Lee, L. Ouyang, D.H. Chang, D. Mahajan, J. Coombs, Y.M. Wang, S.I. Alexander, and D.C. Harris Ex vivo programmed macrophages ameliorate experimental chronic inflammatory renal disease Kidney Int 72 2007 290 299
41. L. Barisoni, W. Kriz, P. Mundel, and V. D'Agati The dysregulated podocyte phenotype: a novel concept in the pathogenesis of collapsing idiopathic focal segmental glomerulosclerosis and HIV-associated nephropathy J Am Soc Nephrol 10 1999 51 61
42. S.J. Shankland The podocyte's response to injury: role in proteinuria and glomerulosclerosis Kidney Int 69 2006 2131 2147
43. L. Lasagni, E. Lazzeri, S.J. Shankland, H.J. Anders, and P. Romagnani Podocyte mitosis-a catastrophe Curr Mol Med 13 2013 13 23
44. S.J. Shankland, J.W. Pippin, and W.G. Couser Complement (C5b-9) induces glomerular epithelial cell DNA synthesis but not proliferation in vitro Kidney Int 56 1999 538 548
45. M. Castedo, J.L. Perfettini, T. Roumier, K. Andreau, R. Medema, and G. Kroemer Cell death by mitotic catastrophe: a molecular definition Oncogene 23 2004 2825 2837
46. C.B. Marshall, R.D. Krofft, J.W. Pippin, and S.J. Shankland CDK inhibitor p21 is prosurvival in adriamycin-induced podocyte injury, in vitro and in vivo Am J Physiol Renal Physiol 298 2010 F1140 F1151
47. C. Thomas, I. Moraga, D. Levin, P.O. Krutzik, Y. Podoplelova, A. Trejo, C. Lee, G. Yarden, S.E. Vleck, J.S. Glenn, G.P. Nolan, J. Piehler, G. Schreiber, and K.C. Garcia Structural linkage between ligand discrimination and receptor activation by type I interferons Cell 146 2011 621 632
48. V.D. D'Agati, F.J. Kaskel, and R.J. Falk Focal segmental glomerulosclerosis N Engl J Med 365 2011 2398 2411
49. A. Migliorini, and H.J. Anders A novel pathogenetic concept-antiviral immunity in lupus nephritis Nat Rev Nephrol 8 2012 183 189
50. S.A. Rich Human lupus inclusions and interferon Science 213 1981 772 775
51. J.M. Gonzalez-Navajas, J. Lee, M. David, and E. Raz Immunomodulatory functions of type I interferons Nat Rev Immunol 12 2012 125 135
52. L.D. Jacobs, R.W. Beck, J.H. Simon, R.P. Kinkel, C.M. Brownscheidle, T.J. Murray, N.A. Simonian, P.J. Slasor, and A.W. Sandrock Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis. CHAMPS Study Group N Engl J Med 343 2000 898 904
53. K. Nakao, H. Sugiyama, E. Makino, H. Matsuura, A. Ohmoto, T. Sugimoto, H. Ichikawa, J. Wada, Y. Yamasaki, and H. Makino Minimal change nephrotic syndrome developing during postoperative interferon-beta therapy for malignant melanoma Nephron 90 2002 498 500
54. S. Ohta, H. Yokoyama, T. Wada, N. Sakai, M. Shimizu, T. Kato, K. Furuichi, C. Segawa, Y. Hisada, and K. Kobayashi Exacerbation of glomerulonephritis in subjects with chronic hepatitis C virus infection after interferon therapy Am J Kidney Dis 33 1999 1040 1048
55. M. Shah, E.H. Jenis, B.K. Mookerjee, J.R. Schriber, M.R. Baer, G.P. Herzig, and M. Wetzler Interferon-alpha-associated focal segmental glomerulosclerosis with massive proteinuria in patients with chronic myeloid leukemia following high dose chemotherapy Cancer 83 1998 1938 1946